Recommendations relating to the prescribing of specific drugs across the health economy DPS001 (Rev) - Exenatide DPS002 (Rev) - Melatonin (Circadin and unlicensed products) DPS003 (Rev) - Aliskiren DPS004 - Sitagliptin DPS005 - Vildagliptin DPS006 (Rev) - Liraglutide DPS007 - Sativex (Review) DPS008 (Rev) - Roflumilast DPS009 (Rev 2) - Dronedarone DPS010 - Capsaicin patch [Qutenza] DPS 011 - Denosumab DPS 012 (Rev) - Saxagliptin DPS013 - Indacaterol DPS014 - Prucalopride DPS015 - N-Acetylcysteine DPS016 - Duloxetine for diabetic peripheral neuropathy DPS017 (Rev) - Ticagrelor DPS018 - Tapentadol SR DPS019 - LMWHs in Pregnancy DPS020 - Febuxostat DPS021 - Linagliptin DPS 022 - Asenapine